Construction of a new Belarusian-Indian pharmaceutical company launched in Skidel. It will produce drugs for the treatment of HIV, cancer and tuberculosis; all in all near 50 types of medications. The price will be lower than European analogues. About $ 3 million were invested in the project. In total, there will be 3 pharmaceutical plants with the Indian capital in Belarus. Construction is a vivid example of the implementation of long-term investment agreements. This should make the Belarusian market more attractive to foreign investors. In the near future the draft decree on long-term investment instruments will be prepared.
